| Date Filed | Type | Description |
| 08/10/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/10/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/13/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/14/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/27/2021 |
GN
| Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference |
| 03/17/2021 |
GN
| Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen |
| 03/05/2021 |
GN
| Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection |
| 02/25/2021 |
GN
| Adaptive Biotechnologies to Present at the Cowen 41st Annual Healthcare Conference |
| 02/23/2021 |
GN
| Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio |
| 02/23/2021 |
GN
| Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection |
| 02/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/03/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/28/2021 |
SC 13D/A
| Steel Excel Inc. reports a 7.8% stake in Aviat Networks, Inc. |
| 01/11/2021 |
GN
| Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics |
| 12/30/2020 |
GN
| Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference |
| 12/22/2020 |
SC 13D/A
| Steel Excel Inc. reports a 10.1% stake in Aviat Networks, Inc. |
| 12/17/2020 |
SC 13D/A
| Steel Excel Inc. reports a 10.2% stake in Aviat Networks, Inc. |
| 12/14/2020 |
SC 13D/A
| Steel Excel Inc. reports a 11.3% stake in Aviat Networks, Inc. |
| 12/06/2020 |
GN
| Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting |
| 11/23/2020 |
GN
| Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients |
| 11/16/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/13/2020 |
GN
| Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms Antibody Testing in Identifying Past SARS-CoV-2 Infections |
| 11/10/2020 |
GN
| Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio |
| 11/10/2020 |
GN
| Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results |
| 10/13/2020 |
GN
| Adaptive Biotechnologies to Report Third Quarter Financial Results on November 10, 2020 |
| 09/01/2020 |
GN
| Adaptive Biotechnologies to Present at the Morgan Stanley 2020 Healthcare Conference |
| 08/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/10/2020 |
GN
| Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit |
|